(19)
(11) EP 3 445 380 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
05.06.2024 Bulletin 2024/23

(45) Mention of the grant of the patent:
10.04.2024 Bulletin 2024/15

(21) Application number: 17720211.6

(22) Date of filing: 19.04.2017
(51) International Patent Classification (IPC): 
A61K 35/742(2015.01)
 A61P 31/04(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 35/742; A61P 1/00; A61P 1/04; A61P 1/16; A61P 11/06; A61P 19/02; A61P 25/00; A61P 25/16; A61P 25/28; A61P 3/00; A61P 3/04; A61P 31/04; A61P 35/00; A61P 3/06; A61P 37/02; A61P 37/08; A61P 43/00; A61P 7/00; A61P 9/00; A61P 3/10; Y02A 50/30
(86) International application number:
PCT/GB2017/051083
(87) International publication number:
WO 2017/182796 (26.10.2017 Gazette 2017/43)

(54)

BACTERIOTHERAPY

BAKTERIOTHERAPIE

BACTÉRIOTHÉRAPIE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 19.04.2016 GB 201606801

(43) Date of publication of application:
27.02.2019 Bulletin 2019/09

(60) Divisional application:
24168584.1

(73) Proprietor: Genome Research Limited
Hinxton, Saffron Walden CB10 1SA (GB)

(72) Inventors:
  • NEVILLE, Anne
    Cambridge Cambridgeshire CB10 1SA (GB)
  • BROWNE, Hilary
    Cambridge Cambridgeshire CB10 1SA (GB)
  • FORSTER, Sam
    Cambridge Cambridgeshire CB10 1SA (GB)
  • LAWLEY, Trevor
    Cambridge Cambridgeshire CB10 1SA (GB)

(74) Representative: Appleyard Lees IP LLP 
15 Clare Road
Halifax HX1 2HY
Halifax HX1 2HY (GB)


(56) References cited: : 
WO-A1-2013/037068
WO-A1-2015/077794
WO-A2-2012/039615
US-A1- 2015 190 435
 WO-A1-2014/121301
WO-A1-2015/156419
US-A1- 2014 147 425
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).